Ryan D Maynard
CIK 1363984 · Chief Financial Officer · last filed 2026-02-24
Ryan D Maynard is a Chief Financial Officer who has filed 39 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for FHTX, was dated Feb 24, 2026. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.32M
5
39
-$1.91M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FHTX | Chief Financial Officer | — | $4.18 | — | $0 | 1 | 2026-02-24 |
| IOVA | Director | 7,500 | $4.08 | $30.6K | -$452.4K | 11 | 2025-06-17 |
| Tvardi Therapeutics, Inc. (CARA) Delisted | CHIEF FINANCIAL OFFICER | 8,012 | $15.96 | $127.9K | -$2.9K | 4 | 2024-02-12 |
| RIGL | EVP & CFO | 100,000 | $32.85 | $3.29M | -$1.45M | 19 | 2017-11-07 |
| IOVANCE BIOTHERAPEUTICS, INC. (LBIO) Delisted | Director | — | — | — | $0 | 3 | 2017-06-05 |
Recent Filings
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-24 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2025-06-17 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2024-11-14 | IOVA | Mixed | — | -$130.5K | EDGAR |
| 2024-06-13 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2024-03-05 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2024-02-12 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −5,488 | -$2.9K | EDGAR |
| 2024-02-05 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | +13,500 | $0 | EDGAR |
| 2023-06-08 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2023-03-03 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-09-14 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | — | $0 | EDGAR |